Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Total Debt (2021 - 2025)

Bioregenx's Total Debt history spans 5 years, with the latest figure at $1.2 million for Q4 2025.

  • Quarterly results put Total Debt at $1.2 million for Q4 2025, up 4.14% from a year ago — trailing twelve months through Dec 2025 was $1.2 million (up 4.14% YoY), and the annual figure for FY2025 was $1.2 million, up 4.14%.
  • Total Debt for Q4 2025 was $1.2 million at Bioregenx, down from $2.3 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $2.3 million in Q3 2025 to a low of $200000.0 in Q4 2021.
  • The 5-year median for Total Debt is $1.1 million (2024), against an average of $1.1 million.
  • The sharpest move saw Total Debt changed 0.0% in 2022, then surged 875.61% in 2024.
  • Year by year, Total Debt stood at $200000.0 in 2021, then changed by 0.0% to $200000.0 in 2022, then soared by 350.68% to $901362.0 in 2023, then grew by 26.24% to $1.1 million in 2024, then increased by 4.14% to $1.2 million in 2025.
  • According to Business Quant data, Total Debt over the past three periods came in at $1.2 million, $2.3 million, and $2.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.